Infant mortality from birth defects in Costa Rica: update 2010-2018

Authors

  • María de la Paz Barboza-Argüello Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud (INCIENSA),
  • Adriana Benavides-Lara Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud (INCIENSA)

DOI:

https://doi.org/10.51481/amc.v63i2.1185

Keywords:

Infant mortality, neonatal mortality, birth defects, Costa Rica

Abstract

Objective. This study aims to identify the trend of the different types of congenital defects in the infant and neonatal mortality rate in Costa Rica during the period 2010-2018, and to compare it with the period 2000-2009.
Methods. A vital statistics analysis was performed. The source of information was the Costa Rican National Institute of Statistics and Censuses, through its public domain system and online consultation, the base of deaths by cause and the base of births for the period 2000-2018 were consulted. The causes of death due to congenital defects were grouped by system, in addition, the defects with the highest mortality in the study period were selected for their specific analysis. To describe the behavior of infant mortality due to congenital defects in 2010-2018 with respect to the previous decade, infant and neonatal mortality rates were calculated for the periods 2000-2009 and 2010-2018 with their respective confidence interval (95% CI). A linear Poisson Log regression model was constructed for each group of congenital defects and for the specific defects selected, taking the sub periods compared as an adjustment factor. Prevalence ratios were estimated and compared using Wald's chi square based on the period 2000-2009.
Results. In the last two decades, birth defects caused 29% to 38% of overall infant mortality. The infant mortality rate due to congenital defects during 2000-2009 was 3.19 (95% CI: 3.06-3.32) and presented a significant decrease to 2.97 (95% CI: 2.84-3.11) in the 2010-2018 period. This decrease occurred at the expense of the affection of circulatory and digestive systems. When analyzing infant mortality due to specific congenital defects, a significant decrease was shown only in spina bifida and some cardiac defects: transposition of the great arteries, ventricular septal defect, aortic coarctation and other unspecified cardiac anomalies. The neonatal mortality rate due to congenital defects did not vary significantly between the periods compared, in 2000-2009 it was 2.13 (95% CI: 2.03-2.24) and 2.17 (95% CI: 2.06-2, 29) in 2010-2018. The only group of congenital defects that presented a significant decrease in the neonatal mortality rate in the last decade was the circulatory system.
Conclusions. In the last decade there was a significant decrease in the infant mortality rate due to congenital defects. This decrease was mainly due to a significant decrease in infant and neonatal mortality rates from heart defects.

Downloads

Download data is not yet available.

References

Kirby RS. The prevalence of selected major birth defects in the United States. Semin Perinatol. 2017;41:338-44.

Toobaie A, Yousef Y, Balvardi S, St-Louis E, Baird R, Guadagno E et al. Incidence and prevalence of congenital anomalies in low-and middle-income countries: a systematic review. J Pediatr Surg. 2019; 54:1089-93.

García H, Salguero GA, Moreno J, Arteaga C, Giraldo A. Frecuencia de anomalías congénitas en el Instituto Materno Infantil de Bogotá. Biomédica 2003; 23:161-72.

Gonzalez RM, Gilleskie D. Infant Mortality Rate as a Measure of a Country's Health: A Robust Method to Improve Reliability and Comparability. Demography. 2017;54:701-20.

Rosero L. Determinantes del descenso de la mortalidad infantil en Costa Rica. Bol Of Sanit Panam. 1985;99:510-26.

Barboza-Arguello MP, Benavides-Lara A, Umaña L, Vargas-Leitón B. Mortalidad infantil por defectos congénitos en Costa Rica, 1981-2010. Rev Panam Salud Publica. 2013;34:304-11.

Colluci C. Brazil's child and maternal mortality have increased against background of public spending cuts. BMJ. 2018; 362: k3583. doi:10.1136/bmj.k3583

Lehtonen L, Gimeno A, Parra-Llorca A, Vento M. Early neonatal death: A challenge worldwide. Semin Fetal Neonatal Med. 2017;22:153-60.

Sarasqueta, P. Mortalidad infantil por malformaciones congénitas y prematurez en la Argentina: análisis de los criterios de reducibilidad. Arch Argent Pediatr. 2006;104:153-8.

Gómez-Alcalá AV, Rascón-Pacheco RA. La mortalidad infantil por malformaciones congénitas en México: un problema de oportunidad y acceso al tratamiento. Rev Panam Salud Publica. 2008;24:297-303.

Hernandez-Trejo M, Llano-Rivas I, Rivera A, Aguinaga-Ríos M, Mayen-Molina D. Mortalidad perinatal por defectos estructurales congénitos: un estudio de caso. Perinatol Reprod Hum. 2007;21:125-31.

Cantón SBF, Martínez AMH, Uribe RV. Mortalidad en menores de un año de edad por malformaciones congénitas del sistema nervioso central. México, 1990-2012. Bol Med Hosp Infant Mex. 2013;70:412-6.

Bronberg R, Schuler-Faccini L, Ramallo V, Alfaro M, Diperri J. Spatial and temporal analysis of infant mortality from congenital malformations in Brazil (1996-2010). J Community Genet. 2014;5:269-82.

Petrini J, Damus KY, Johnston R. An overview of infant mortality and birth defects in the United States. Teratology. 1997;56:8-9.

Petrini J, Dannus K, Rusell R. Contributionof birth defects to infant mortality in the United States. Teratology. 2002;66:3-6.

Almli LM, Ely DM, Ailes EC, Abouk R, Grosse SD, Isenburg JL, et al. Infant Mortality Attributable to Birth Defects — United States, 2003-2017. MMWR Morb Mortal Wkly Rep. 2020;69:25-9.

Benavides-Lara A, Faerron, JE, Umaña L, Romero-Zuñiga JJ. Epidemiología y registro de las cardiopatías congénitas en Costa Rica. Rev Panam Salud Publica. 2011;30:31-8.

Barboza MP, Umaña L. Impacto de la fortificación con ácido-fólico en los defectos del tubo neural en Costa Rica. Rev Panam Salud Pública. 2011;30:1-6.

Petrini J, Damus K, Jonston RB. Trends in infant mortality attributable to birth defects - United States, 1980-1995. MMWR Morb Mortal Wkly Rep. 1998;47:773-8.

Benavides-Lara A, Barboza-Argüello MP. Prevalencia al nacimiento de síndrome de Down, según edad materna en Costa Rica, 1996-2016. Acta Med Costarric. 2019;61:177-82.

Barboza-Argüello MP, Benavides-Lara A. Prevalencia al nacimiento de gastrosquisis y onfalocele en Costa Rica. Acta Med Costarric. 2018;60:35-41.

Phillips DE, Lozano R, Naghavi M, Atkinson C, Gonzalez-Medina D, Mikkelsen L, et al. A composite metric for assessing data on mortality and causes of death: the vital statistics performance index. Popul Health Metrics. 2014;12:14.

Published

2021-10-31

How to Cite

Infant mortality from birth defects in Costa Rica: update 2010-2018. (2021). Acta Médica Costarricense , 63(2), 88-96. https://doi.org/10.51481/amc.v63i2.1185